High-dose cyclophosphamide therapy for malignant disease.Toxicity, tumor response, and the effects of stored autologous marrow
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROME
1968 • 873 citations
Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered <italic>In Vivo</italic><xref ref-type="fn" rid="FN2">2</xref>
1966 • 537 citations
Technique for Human Marrow Grafting
1970 • 483 citations
Meaningful clinical classification of therapeutic responses to anticancer drugs
1961 • 212 citations
The African lymphoma:Preliminary observations on response to therapy
1965 • 130 citations
Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
1970 • 93 citations
Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide)
1960 • 70 citations
NITROGEN-MUSTARD THERAPY COMBINED WITH AUTOLOGOUS MARROW INFUSION
1961 • 63 citations
Autologous and Isologous Bone Marrow Storage and Infusion in the Treatment of Myelo‐Suppression*
1962 • 46 citations
Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide.
1969 • 38 citations
The Clinical Application of Bone Marrow Grafting
1962 • 37 citations
Low temperature preservation of monkey marrow in dimethyl sulfoxide
1970 • 34 citations
Effect of large intermittent intravenous doses of cyclophosphamide in lymphoma
1970 • 27 citations
Infusion of Marrow in the Mouse and Dog after Thio-TEPA
1963 • 16 citations
Isogeneic Marrow Infusion Following Nitrogen Mustard in the Dog.
1965 • 5 citations